查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470428

心臟標記物市場：按產品、生物標記類型、最終用戶、適應症 - 全球預測 2024-2030

Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

心臟標記物市場規模預計2023年為38.1億美元，預計2024年將達到41.6億美元，2030年將達到72.9億美元，複合年成長率為9.71%。

心臟標記是在血液中測量的物質或分子，用於診斷和監測各種心臟狀況，特別是與心肌損傷和壓力相關的狀況。這些標記物通常用於醫院和實驗室等臨床環境中，以幫助心血管疾病的診斷、預後和監測。尤其廣泛應用於心肌梗塞和其他急性冠狀動脈症候群的診斷。心血管疾病（CVD）準確、早期診斷的重要性日益增加，心臟標記市場的評估也逐漸提高。心血管疾病盛行率的上升和全球老年人口的增加正在推動心臟標記的市場需求。對照護現場檢測的需求不斷成長，醫療基礎設施（包括設備齊全的實驗室和訓練有素的人員）的穩定發展正在推動全球產業的成長。然而，與心血管手術和解決方案相關的高價格正在影響市場採用。生物醫學行業的進步，特別是診斷技術的進步，以及旨在促進預防性醫療保健的政府醫療保健舉措和計劃，正在幫助擴大對心臟標誌物的需求，並為市場創造巨大的成長機會。

主要市場統計
基準年[2023] 38.1億美元
預測年份 [2024] 41.6億美元
預測年份 [2030] 72.9億美元
複合年成長率（%） 9.71%

產品：試劑和套件提供心臟特異性蛋白質的定性和定量評估

化學發光免疫測量(CLIA) 系統是先進的診斷儀器，可偵測敏感的心臟標記物，如肌鈣蛋白、CK-MB 和肌紅蛋白。這些裝置利用發光基材，在目標抗原存在的情況下與特定酵素反應時發光。酵素結合免疫吸附檢測法(ELISA)套件和設備對於心臟標記的檢測和定量至關重要。這些測定依賴於產生可測量的比色變化的酶結合反應。 ELISA 系統在可擴展性方面非常彈性，並以其特異性和高靈敏度而聞名。免疫層析法是一種快速簡單的診斷技術，利用顆粒透過毛細管作用沿著膜移動。抗體和抗原用於檢測特定的生物標記物，例如心臟標記。螢光是一種使用螢光染料或標記物來檢測特定抗體或抗原是否存在的技術，用於對心臟標記物進行更詳細和特異性的分析。用於心臟標記檢測的試劑和套件由針對各種分析平台最佳化的多種免疫測量組成。這些消耗品通常包括專為心臟特異性蛋白質的定性和定量評估而設計的抗體、抗原、緩衝液和基材。

生物標記類型：BNP 和 NT-proBNP 生物標記在心臟衰竭診斷和治療中的採用率很高

BNP 和 NT-proBNP 是診斷和治療心臟衰竭的生物標記。 BNP 從心室肌肉細胞中排放，以應對心臟衰竭典型的體液超負荷導致的室壁張力增加。當這些胜肽被檢測到低水平時，它們對心臟風險和心臟衰竭具有強烈的陰性預測價值。相反，高水平表明不良心血管事件的風險增加。肌酸激酶-MB（CK-MB）是肌酸激酶（CK）的同功異構酵素，是診斷心肌梗塞（MI）的傳統生物標記之一。它主要存在於心肌細胞中，當心肌細胞死亡時，其在血液中增加。高敏性C反應蛋白（Hs-CRP）是一種急性時相蛋白，也是一種指示全身性發炎的特異性發炎生物標記。它通常用於評估心臟疾病和其他心臟危險因素的風險。肌紅蛋白是心肌損傷的早期標記物，但不具有特異性。它與更特異性的心臟標記（例如肌鈣蛋白）結合使用最有用，可用於心肌梗塞的早期評估。肌鈣蛋白 I 和 T 是調節蛋白，是心肌收縮裝置的一部分，是心肌損傷的高度特異性和敏感的生物標記。

最終用戶：在測試設施中更多地使用心臟標記物

實驗室測試設施通常擁有先進的設備和熟練的員工，可以進行全面的測試。醫院和獨立診斷實驗室是該細分市場的主要組成部分。他們提供準確、大容量的心臟標記檢測服務，這對於診斷各種心血管疾病至關重要，包括心肌梗塞（心臟病發作）和急性冠狀動脈症候群。即時護理 (POC) 檢測設施包括急診室、救護車、診所和醫生辦公室。即時結果有助於快速做出臨床決策，對於心臟緊急情況的處理至關重要。肌鈣蛋白、BNP（B 型利鈉胜肽）和 D-二聚體等心臟標記的 POC 檢測徹底改變了心血管疾病的診斷和管理。心臟標記 POCT 系統設計簡單、快速，可縮短急診護理環境中決策的周轉時間。

採用心臟標記物治療鬱血性心臟衰竭的可能性

在鬱血性心臟衰竭（CHF）中，心臟標記對於診斷、預後和治療非常重要。 B 型利鈉胜肽(BNP) 和 N 端 BNP 前體 (NT-proBNP) 是用於確認疑似 CHF、將其與呼吸困難的其他原因區分開並評估嚴重程度的主要分子。 BNP 或 NT-proBNP 升高與心臟衰竭相關，這些標記可用於 CHF 患者的診斷和監測。在心肌梗塞 (MI) 中，肌鈣蛋白 I、肌鈣蛋白 T 和肌酸激酶 MB (CK-MB) 常被用作心肌梗塞的心臟標記。肌鈣蛋白是檢測心肌損傷的敏感且特異性的標記物。肌鈣蛋白升高表示心肌梗塞，有助於診斷急性冠狀動脈症候群。

區域洞察

美洲由於心血管疾病盛行率高、醫療設施發達、市場參與企業眾多，市場格局顯著。心臟病發病率的增加以及對早期診斷和早期治療的強烈興趣正在推動該地區對心臟標記檢測的需求。此外，生物技術領域的進步和新型診斷技術的高採用率也促進了美國心臟標記市場的成長。歐洲心臟標記市場的成長是由更容易患心臟疾病等慢性疾病的人口老化所推動的。最先進的醫療設施、不斷上漲的醫療成本以及有利的監管政策也支持了歐洲心臟標記市場的成長。此外，在心臟生物標記領域，多個主要市場參與企業和持續的研究活動正在進一步刺激市場成長。預計亞太地區心臟標記市場在預測期內將呈現顯著成長。這是由於新興經濟體人口基數大、文明病盛行率上升以及醫療基礎設施改善緩慢。

FPNV定位矩陣

FPNV定位矩陣對於評估心臟標記市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對心臟標記物市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該細分市場競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動和突破性產品開發的智力見解。

本報告解決了以下關鍵問題：

1.心臟標記物市場的市場規模與預測是多少？

2.在心臟標記物市場預測期內，我們應該考慮投資哪些產品和應用？

3.心臟標記市場的技術趨勢和法規結構是什麼？

4.心臟標記市場主要廠商的市場佔有率是多少？

5. 進入心臟標記物市場的合適形式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病發生率增加
      • 獲得各種心臟生物標記試劑和套件
      • 改善各國的衛生基礎設施和支出
    • 抑制因素
      • 與心血管手術和治療相關的高價格
    • 機會
      • 心臟標記的持續進步
      • 不斷改進照護現場解決方案的性質
    • 任務
      • 心臟標誌物的嚴格法規和核准
  • 市場區隔分析
    • 產品：提供心臟特異性蛋白質定性和定量評估的試劑和套件
    • 生物標記類型：BNP 和 NT-proBNP 生物標記在心臟衰竭診斷和治療中的採用率較高
    • 最終用戶：實驗室測試設施中心臟標記物的關鍵使用
    • 適應症：心臟標記在鬱血性心臟衰竭的潛在應用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章心臟標記市場：依產品

  • 介紹
  • 裝置
  • 試劑和套件

第7章心臟標記市場：依生物標記類型

  • 介紹
  • BNP 或 NT-ProBNP
  • CK-MB
  • Hs-CRP
  • 肌紅蛋白
  • 肌鈣蛋白 I 和 T

第8章心臟標記物市場：依最終用戶分類

  • 介紹
  • 實驗室測試設施
  • 照護現場偵測設施

第9章心臟標記市場：依適應症分類

  • 介紹
  • 心臟衰竭性鬱血性
  • 心肌梗塞

第10章美洲心臟標記物市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太心臟標記物市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲心臟標記市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-034230D3E2D1

[189 Pages Report] The Cardiac Marker Market size was estimated at USD 3.81 billion in 2023 and expected to reach USD 4.16 billion in 2024, at a CAGR 9.71% to reach USD 7.29 billion by 2030.

Cardiac markers are substances or molecules measured in the blood to diagnose and monitor various cardiac conditions, particularly those related to heart muscle damage or stress. These markers are often used in clinical settings, such as hospitals and laboratories, to assist in diagnosing, prognosis, and monitoring cardiovascular diseases. They are particularly widely used in the diagnosis of conditions such as myocardial infarction and other forms of acute coronary syndrome. With an increased emphasis on accurate and early diagnosis in cases of cardiovascular diseases (CVD), the cardiac markers market's valuation has been progressively escalating. The rising incidence of cardiovascular conditions and the growing global geriatric population fuel the market demand for cardiac markers. Rising demand for point-of-care testing and the steady development in healthcare infrastructure, including well-equipped labs and trained personnel, globally aids the industry's growth. However, High prices associated with cardiovascular procedures and solutions affect market adoption. The evolution of the biomedical industry, particularly diagnostic technologies, and government healthcare initiatives and programs aiming to foster preventative care are instrumental in escalating the demand for cardiac markers and creating a significant growth opportunity for the market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.81 billion
Estimated Year [2024] USD 4.16 billion
Forecast Year [2030] USD 7.29 billion
CAGR (%) 9.71%

Product: Reagents and kits provide qualitative and quantitative assessment of cardiac-specific proteins

Chemiluminescence immunoassay (CLIA) systems are sophisticated diagnostic instruments that detect high-sensitivity cardiac markers such as troponin, CK-MB, and myoglobin. These instruments utilize luminogenic substrates that emit light upon reaction with specific enzymes in the presence of the targeted antigen. Enzyme-linked immunosorbent assay (ELISA) kits and instruments are vital in detecting and quantifying cardiac markers. These assays rely on an enzyme-conjugate reaction that produces a measurable colorimetric change. ELISA systems offer flexibility in terms of scalability and are known for their specificity and high sensitivity. Immunochromatography is a rapid and simple diagnostic technique that utilizes the movement of particles along a membrane via capillary action. It involves using antibodies and antigens to detect specific biomarkers, such as cardiac markers. Immunofluorescence is a technique that uses fluorescent dyes or markers to detect the presence of specific antibodies or antigens, and it is employed for more detailed and specific analysis in the context of cardiac markers. Reagents and kits for cardiac marker detection comprise a wide range of immunoassays optimized for various analytical platforms. These consumables often include antibodies, antigens, buffers, and substrates specifically engineered for the qualitative and quantitative assessment of cardiac-specific proteins.

Biomarker Type: High adoption of BNP and NT-proBNP biomarkers for diagnosing and managing heart failure

BNP and NT-proBNP are biomarkers for diagnosing and managing heart failure. BNP is discharged by ventricular myocytes in reaction to increased wall tension, typically due to fluid overload in heart failure. When found at low levels, these peptides have a strong negative predictive value for cardiac risk and heart failure. In contrast, elevated levels are indicative of an increased risk of adverse cardiovascular events. Creatine Kinase-MB (CK-MB) is an isoenzyme of creatine kinase (CK) and is one of the traditional biomarkers for diagnosing myocardial infarction (MI). It is found mainly in cardiac cells and increases in the blood following the death of heart muscle cells. High-sensitivity C-Reactive Protein (Hs-CRP) is an acute-phase protein and a non-specific inflammatory biomarker that can indicate systemic inflammation. It is often used to assess the risk of cardiac disease and other cardiac risk factors. Myoglobin is an early but non-specific marker of myocardial injury. It is most valuable when used alongside more specific cardiac markers, such as troponins, for the early assessment of myocardial infarction. Troponin I and T are regulatory proteins that are part of the cardiac muscle contractile apparatus and are highly specific and sensitive biomarkers for myocardial injury.

End-User: Significant utilization of cardiac marker in laboratory testing facilities

Laboratory testing facilities are typically equipped with sophisticated equipment and skilled personnel capable of performing a comprehensive range of tests. Hospitals and independent diagnostic labs are the primary constituents of this sector. They offer accurate and high-volume cardiac marker testing services, integral for diagnosing various cardiovascular conditions, including myocardial infarctions (heart attacks) and acute coronary syndromes. Point of Care (POC) testing facilities include emergency departments, ambulances, clinics, and physician offices. The immediacy of results allows for swift clinical decision-making, critical in managing cardiac emergencies. POC testing for cardiac markers, such as troponin, BNP (B-type natriuretic peptide), and D-dimer, has revolutionized diagnosing and managing cardiovascular diseases. POCT systems for cardiac markers are designed for simplicity and speed, reducing the turnaround time for decision-making in acute care settings.

Indication: Potential adoption of cardiac markers in congestive heart failure situations

In congestive heart failure (CHF) situations, cardiac markers are crucial in diagnosis, prognosis, and management. B-type natriuretic peptide (BNP) and N-terminal-pro BNP (NT-proBNP) are the primary biomarkers used to confirm suspected CHF, differentiate it from other causes of dyspnea, and assess the severity of the condition. Elevated levels of BNP or NT-proBNP are associated with heart failure, and these markers are used for both diagnosis and monitoring of CHF patients. In myocardial infarction (MI), Troponin I, Troponin T, and creatine kinase-MB (CK-MB) are commonly used cardiac markers for myocardial infarction. Troponins are sensitive and specific markers for detecting myocardial injury. Elevated levels of troponins indicate myocardial infarction and help in diagnosing acute coronary syndrome.

Regional Insights

The Americas has a significant market landscape in the cardiac marker market due to a high prevalence of cardiovascular diseases, well-established healthcare facilities, and major market players. The increasing incidence of heart attacks and the strong focus on early diagnosis and treatment are driving the demand for cardiac marker tests in this region. Moreover, advancements in the biotechnology sector and higher adoption rates for novel diagnostics methodologies contribute to America's cardiac marker market growth. Europe's market growth in the cardiac marker is propelled by the rising aging population, which is more prone to chronic diseases, including coronary heart disease. The availability of cutting-edge healthcare facilities, rising healthcare expenditures, and favorable regulatory policies also support the growth of the European cardiac marker market. Moreover, several key market players and ongoing research activities in the cardiac biomarkers space further stimulate market growth. The Asia-Pacific region is projected to show a significant cardiac marker market growth rate during the forecast period attributed to the large population base, the rising incidences of lifestyle diseases, and the gradual improvement in healthcare infrastructure across emerging economies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Marker Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Marker Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aehealth Limited, Becton, Dickinson and Company, BG Medicine Inc., Bio-Rad Laboratories, Inc., Biomerieux SA, Danaher Corporation, DiaSorin S.P.A., HyTest Ltd., LSI Medience Corporation, PerkinElmer Inc., QuidelOrtho Corporation, Randox Laboratories Ltd., Roche Diagnostics Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
      • Chemiluminescence
      • ELISA
      • Immunochromatography
      • Immunofluorescence
    • Reagents & Kits
  • Biomarker Type
    • BNP Or NT-ProBNP
    • CK-MB
    • Hs-CRP
    • Myoglobin
    • Troponin I & T
  • End-User
    • Laboratory Testing Facilities
    • Point of Care Testing Facilities
  • Indication
    • Congestive Heart Failure
    • Myocardial Infarction
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiac Marker Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Marker Market?

3. What are the technology trends and regulatory frameworks in the Cardiac Marker Market?

4. What is the market share of the leading vendors in the Cardiac Marker Market?

5. Which modes and strategic moves are suitable for entering the Cardiac Marker Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing occurrence of cardiovascular diseases
      • 5.1.1.2. Accessibility to a large variety of reagents and kits for cardiac biomarkers
      • 5.1.1.3. Improved healthcare infrastructure and spending across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High prices associated with cardiovascular procedures and solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in cardiac markers
      • 5.1.3.2. Persistent improvement in the essence of point-of-care diagnostic solution
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and approvals for cardiac markers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Reagents and kits provide qualitative and quantitative assessment of cardiac-specific proteins
    • 5.2.2. Biomarker Type: High adoption of BNP and NT-proBNP biomarkers for diagnosing and managing heart failure
    • 5.2.3. End-User: Significant utilization of cardiac marker in laboratory testing facilities
    • 5.2.4. Indication: Potential adoption of cardiac markers in congestive heart failure situations
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cardiac Marker Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits

7. Cardiac Marker Market, by Biomarker Type

  • 7.1. Introduction
  • 7.2. BNP Or NT-ProBNP
  • 7.3. CK-MB
  • 7.4. Hs-CRP
  • 7.5. Myoglobin
  • 7.6. Troponin I & T

8. Cardiac Marker Market, by End-User

  • 8.1. Introduction
  • 8.2. Laboratory Testing Facilities
  • 8.3. Point of Care Testing Facilities

9. Cardiac Marker Market, by Indication

  • 9.1. Introduction
  • 9.2. Congestive Heart Failure
  • 9.3. Myocardial Infarction

10. Americas Cardiac Marker Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Marker Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Marker Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
    • 13.3.2. AUDIT MicroControls, Inc. Announces Linearity FLQ Cardiac Markers for Roche Systems
    • 13.3.3. Cipla Launches Diagnostic Device For Multiple Health Conditions
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARDIAC MARKER MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC MARKER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC MARKER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARDIAC MARKER MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CARDIAC MARKER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CARDIAC MARKER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC MARKER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC MARKER MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC MARKER MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC MARKER MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC MARKER MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC MARKER MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC MARKER MARKET SIZE, BY ELISA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC MARKER MARKET SIZE, BY ELISA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC MARKER MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC MARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC MARKER MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC MARKER MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC MARKER MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC MARKER MARKET SIZE, BY CK-MB, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC MARKER MARKET SIZE, BY CK-MB, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC MARKER MARKET SIZE, BY HS-CRP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC MARKER MARKET SIZE, BY HS-CRP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOGLOBIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC MARKER MARKET SIZE, BY TROPONIN I & T, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC MARKER MARKET SIZE, BY TROPONIN I & T, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC MARKER MARKET SIZE, BY LABORATORY TESTING FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC MARKER MARKET SIZE, BY LABORATORY TESTING FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC MARKER MARKET SIZE, BY POINT OF CARE TESTING FACILITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC MARKER MARKET SIZE, BY POINT OF CARE TESTING FACILITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC MARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC MARKER MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC MARKER MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES CARDIAC MARKER MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND CARDIAC MARKER MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR CARDIAC MARKER MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR CARDIAC MARKER MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR CARDIAC MARKER MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR CARDIAC MARKER MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR CARDIAC MARKER MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR CARDIAC MARKER MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR CARDIAC MARKER